<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Deoxyuridine triphosphatase (dUTPase) catalyses the hydrolysis of <z:chebi fb="0" ids="17625">dUTP</z:chebi> to <z:chebi fb="3" ids="17622">dUMP</z:chebi> and <z:chebi fb="2" ids="18361">pyrophosphate</z:chebi> thus preventing the incorporation of <z:chebi fb="0" ids="17568">uracil</z:chebi> into replicating DNA </plain></SENT>
<SENT sid="1" pm="."><plain>Previous studies of several virus models have suggested that <z:mp ids='MP_0001799'>viral</z:mp> dUTPases may be required for virus replication in resting cells whereas in proliferating cells cellular dUTPase may substitute for a mutant <z:mp ids='MP_0001799'>viral</z:mp> protein </plain></SENT>
<SENT sid="2" pm="."><plain>Using monoclonal antibodies and immunohistochemistry, Epstein-Barr virus-associated non-neoplastic and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">neoplastic diseases</z:e> were studied for the expression of <z:mp ids='MP_0001799'>viral</z:mp> and human dUTPases </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0206186" disease_type="Neoplastic Process" abbrv="">Oral hairy leukoplakia</z:e>, an <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e>-associated lesion of the tongue, is known to support EBV replication in the upper epithelial cell layers </plain></SENT>
<SENT sid="4" pm="."><plain>In agreement with this, strong focal expression of EBV dUTPase was detected in the upper epithelial cell layers of <z:e sem="disease" ids="C0206186" disease_type="Neoplastic Process" abbrv="">oral hairy leukoplakia</z:e> whereas expression of human dUTPase was confined to the basal proliferative cell compartment </plain></SENT>
<SENT sid="5" pm="."><plain>Furthermore, in <z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">infectious mononucleosis</z:e> tonsils, rare scattered small lymphoid cells expressed EBV dUTPase, consistent with the expression pattern of other EBV lytic cycle antigens </plain></SENT>
<SENT sid="6" pm="."><plain>These findings are in agreement with the notion that EBV replicates in resting cells </plain></SENT>
<SENT sid="7" pm="."><plain>Three EBV-associated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e>, Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and nasopharyngeal <z:mp ids='MP_0002038'>carcinoma</z:mp>, lacked detectable expression of EBV dUTPase, in agreement with the notion that <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> is largely latent in these <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>By contrast, expression of human dUTPase was observed regularly in these <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>These results suggest that EBV dUTPase may be a suitable target for anti-<z:mp ids='MP_0001799'>viral</z:mp> therapy and that inhibitors of human dUTPase should prove useful for the treatment of human <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e>, including EBV-associated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
</text></document>